Other
Gross Unrealized Gains
CVS Health Gross Unrealized Gains decreased by 45.4% to $245M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 0.4%, from $246M to $245M. Over 5 years (FY 2020 to FY 2025), Gross Unrealized Gains shows a downward trend with a -24.3% CAGR.
Analysis
StatementBalance Sheet Statement
SectionOther
First reportedQ4 2018
Last reportedQ1 2026May 6, 2026
Metric ID:
other_available_for_sale_debt_securities_accumulated_gro_8d5dbcHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.44B | $1.31B | $1.17B | $428M | $65M | $26M | $57M | $101M | $69M | $35M | $267M | $191M | $146M | $510M | $178M | $246M | $347M | $462M | $449M | $245M |
| QoQ Change | — | -8.9% | -10.7% | -63.5% | -84.8% | -60.0% | +119.2% | +77.2% | -31.7% | -49.3% | +662.9% | -28.5% | -23.6% | +249.3% | -65.1% | +38.2% | +41.1% | +33.1% | -2.8% | -45.4% |
| YoY Change | — | — | — | — | -95.5% | -98.0% | -95.1% | -76.4% | +6.2% | +34.6% | +368.4% | +89.1% | +111.6% | >999% | -33.3% | +28.8% | +137.7% | -9.4% | +152.2% | -0.4% |
Range$26M – $1.44B
CAGR-31.1%
Avg YoY Growth+117.3%
Median YoY Growth+17.5%
Current Streak2 quarters decline
Product Breakdown
| Segment | Q4 '25 |
|---|---|
| Supporting Experience-Rated Products | $10M |
| Total | $449M |
Gross Unrealized Gains at Other Companies
Frequently Asked Questions
- What is CVS Health's gross unrealized gains?
- CVS Health (CVS) reported gross unrealized gains of $245M in Q1 2026.
- How has CVS Health's gross unrealized gains changed year-over-year?
- CVS Health's gross unrealized gains decreased by 0.4% year-over-year, from $246M to $245M.
- What is the long-term trend for CVS Health's gross unrealized gains?
- Over 5 years (2020 to 2025), CVS Health's gross unrealized gains has grown at a -24.3% compound annual growth rate (CAGR), from $1.8B to $449M.